Date | Time | Source | Headline | Symbol | Company |
06/07/2024 | 2:15PM | iHub Newswire | FeaturedDaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio | | |
11/07/2011 | 8:30AM | Business Wire | Gilead Sciences & Cardiovascular Research Foundation Initiate Phase 3 Clinical Trial with Ranolazine in Patients Who Have Und... | NASDAQ:GILD | Gilead Sciences Inc |
11/05/2011 | 9:00AM | Business Wire | Gilead Announces Positive Five-Year Data Showing Effect of Viread® on Liver Fibrosis & Cirrhosis Caused by Chronic Hepatitis B | NASDAQ:GILD | Gilead Sciences Inc |
11/04/2011 | 4:51PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:GILD | Gilead Sciences Inc |
11/03/2011 | 8:00PM | Zacks | Celgene Buy Opportunity - Tactical Trading | NASDAQ:GILD | Gilead Sciences Inc |
11/03/2011 | 8:00PM | Zacks | Celgene Buy Opportunity - Tactical Trading | NASDAQ:GILD | Gilead Sciences Inc |
11/03/2011 | 5:18PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
11/03/2011 | 4:18PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
11/01/2011 | 5:57PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
10/28/2011 | 2:19PM | Zacks | Gilead a Cent Ahead, Files Quad NDA - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
10/28/2011 | 9:13AM | Dow Jones News | US Stock Futures: HOT STOCKS TO WATCH | NASDAQ:GILD | Gilead Sciences Inc |
10/28/2011 | 8:11AM | Dow Jones News | US Stock Futures: HOT STOCKS TO WATCH | NASDAQ:GILD | Gilead Sciences Inc |
10/27/2011 | 4:27PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
10/27/2011 | 4:27PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
10/27/2011 | 4:05PM | Business Wire | Gilead Sciences Announces Third Quarter 2011 Financial Results | NASDAQ:GILD | Gilead Sciences Inc |
10/27/2011 | 4:03PM | Business Wire | Gilead Submits New Drug Application to U.S. FDA for Once-Daily, Single-Tablet “Quad” HIV Regimen | NASDAQ:GILD | Gilead Sciences Inc |
10/26/2011 | 5:46PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
10/26/2011 | 8:30AM | Business Wire | Bristol-Myers Squibb & Gilead Sciences Announce Licensing Agreement for Development & Commercialization of New Fixed-Dose Com... | NASDAQ:GILD | Gilead Sciences Inc |
10/25/2011 | 5:15AM | Zacks | Actelion Tops, Currency Plays Spoil - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
10/24/2011 | 4:25PM | Business Wire | Gilead & GlobeImmune Announce License & Collaboration Agreement to Develop Therapeutic Vaccine Products for Treatment of Chro... | NASDAQ:GILD | Gilead Sciences Inc |
10/20/2011 | 4:30PM | Business Wire | Gilead Sciences to Release Third Quarter 2011 Financial Results on Thursday, October 27, 2011 | NASDAQ:GILD | Gilead Sciences Inc |
10/18/2011 | 4:31PM | Dow Jones News | 2nd UPDATE: FDA Chemist Pleads Guilty To Insider Trading | NASDAQ:GILD | Gilead Sciences Inc |
10/12/2011 | 5:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
10/06/2011 | 9:22AM | Zacks | Gilead's Quad Gears Up for Filing - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
10/06/2011 | 8:15AM | Marketwired | Equity Research on Gilead Sciences Inc. and Human Genome Sciences Inc. - Regulatory Approval Key for Biotech Companies | NASDAQ:GILD | Gilead Sciences Inc |
10/05/2011 | 8:35PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
10/05/2011 | 6:25PM | Business Wire | Gilead and Boehringer Ingelheim Sign License Agreement for Novel HIV Non-Catalytic Integrase Inhibitors | NASDAQ:GILD | Gilead Sciences Inc |
09/28/2011 | 8:16AM | Marketwired | Momenta Pharmaceuticals and Gilead Sciences Brace for More Competition | NASDAQ:GILD | Gilead Sciences Inc |
09/27/2011 | 9:31AM | PR Newswire (US) | Critical Alerts for ConocoPhillips, Gilead, F5 Networks, Cognizant Technology, and Barclays Released by Seven Summits Research | NASDAQ:GILD | Gilead Sciences Inc |
09/27/2011 | 8:44AM | Zacks | Gilead's Eviplera Backed in EU - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |